Individual MHCI-restricted T-cell receptors are characterized by a unique peptide recognition signature

Frontiers in Immunology

Volumn 4, Issue JUL, 2013, Pages

  Wooldridge, Linda ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Alloreactivity; Autoimmunity; MHCI peptide length; T cell crossreactivity; Vaccination

Indexed keywords

EPITOPE; T LYMPHOCYTE RECEPTOR;

AMINO ACID SEQUENCE; ARTICLE; CD8+ T LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; COMBINATORIAL LIBRARY; DEGENERATION; GRAFT REJECTION; HUMAN; IMMUNITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR RECOGNITION; NONHUMAN; PEPTIDE RECOGNITION; PHENOTYPE;

EID: 84883707090     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00199     Document Type: Article

References (54)

1. Rudolph MG, Stanfield RL, Wilson IA. How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol (2006) 24:419-66. doi:10.1146/annurev.immunol.23.021704.115658
2. Burrows SR, Rossjohn J, McCluskey J. Have we cut ourselves too short in mapping CTL epitopes? Trends Immunol (2006) 27:11-6. doi:10.1016/j.it.2005.11.001
3. Theobald M, Biggs J, Hernandez J, Lustgarten J, Labadie C, Sherman LA. Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes. J Exp Med (1997) 185:833-41. doi:10.1084/jem.185.5.833
4. +T cell responses to EBV EBNA1: HLA class I presentation of the (Gly-Ala)- containing protein requires exogenous processing. Immunity (1997) 7:791-802. doi:10.1016/S1074-7613(00)80397-0
5. Missale G, Redeker A, Person J, Fowler P, Guilhot S, Schlicht HJ, et al. HLA-A31-and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis. J Exp Med (1993) 177:751-62. doi:10.1084/jem.177.3.751
6. Green KJ, Miles JJ, Tellam J, Van Zuylen WJ, Connolly G, Burrows SR. Potent T cell response to a class I-binding 13-mer viral epitope and the influence of HLA micropolymorphism in controlling epitope length. Eur J Immunol (2004) 34:2510-9. doi:10.1002/eji.200425193
7. Yewdell JW, Reits E, Neefjes J. Making sense of mass destruction: quantitating MHC class I antigen presentation. Nat Rev Immunol (2003) 3:952-61. doi:10.1038/nri1250
8. Blum JS, Wearsch PA, Cresswell P. Pathways of antigen processing. Annu Rev Immunol (2013) 31:443-73. doi:10.1146/annurev-immunol-032712-095910
9. Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today (1998) 19:395-404. doi:10.1016/S0167-5699(98)01299-7
10. Arstila TP, Casrouge A, Baron V, Even J, Kanellopoulos J, Kourilsky P. A direct estimate of the human alphabeta T cell receptor diversity. Science (1999) 286:958-61. doi:10.1126/science.286.5441.958
11. Hemmer B, Fleckenstein BT, Vergelli M, Jung G, McFarland H, Martin R, et al. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med (1997) 185:1651-9. doi:10.1084/jem.185.9.1651
12. Hausmann S, Martin M, Gauthier L, Wucherpfennig KW. Structural features of autoreactive TCR that determine the degree of degeneracy in peptide recognition. J Immunol (1999) 162:338-44. Pubmed Abstract | Pubmed Full Text
13. Kissler S, Anderton SM, Wraith DC. Cross-reactivity and T-cell receptor antagonism of myelin basic protein-reactive T cells is modulated by the activation state of the antigen presenting cell. J Autoimmun (2002) 19:183-93. doi:10.1006/jaut.2002.0614
14. Nino-Vasquez JJ, Allicotti G, Borras E, Wilson DB, Valmori D, Simon R, et al. A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol Immunol (2004) 40:1063-74. doi:10.1016/j.molimm.2003.11.005
15. Crawford F, Huseby E, White J, Marrack P, Kappler JW. Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol (2004) 2::E90. doi:10.1371/journal.pbio.0020090
16. Lee JK, Stewart-Jones G, Dong T, Harlos K, Di Gleria K, Dorrell L, et al. T cell cross-reactivity and conformational changes during TCR engagement. J Exp Med (2004) 200:1455-66. doi:10.1084/jem.20041251
17. Kan-Mitchell J, Bajcz M, Schaubert KL, Price DA, Brenchley JM, Asher TE, et al. Degeneracy and repertoire of the human HIV-1 Gag p17(77-85) CTL response. J Immunol (2006) 176:6690-701. Pubmed Abstract | Pubmed Full Text
18. Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, et al. Quantitating T cell cross-reactivity for unrelated peptide antigens. J Immunol (2009) 183:4337-45. doi:10.4049/jimmunol.0901607
19. Houghten RA, Pinilla C, Blondelle SE, Appel JR, Dooley CT, Cuervo JH. Generation and use of synthetic peptide combinatorial libraries for basic research and drug discovery. Nature (1991) 354:84-6. doi:10.1038/354084a0
20. Pinilla C, Appel JR, Judkowski V, Houghten RA. Identification of B cell and T cell epitopes using synthetic peptide combinatorial libraries. Curr Protoc Immunol (2012) Chapter 9:Unit9.5. doi:10.1002/0471142735.im0905s99
21. Rubio-Godoy V, Dutoit V, Zhao Y, Simon R, Guillaume P, Houghten R, et al. Positional scanning-synthetic peptide library-based analysis of self- and pathogenderived peptide cross-reactivity with tumor-reactive Melan-A-specific CTL. J Immunol (2002) 169:5696-707.
22. Hiemstra HS, van Veelen PA, Willemen SJ, Benckhuijsen WE, Geluk A, de Vries RR, et al. Quantitative determination of TCR cross-reactivity using peptide libraries and protein databases. Eur J Immunol (1999) 29:2385-91. doi:10.1002/(SICI)1521-4141(199908)29:08<2385::AID-IMMU2385>;3.3.CO;2-2
23. Maynard J, Petersson K, Wilson DH, Adams EJ, Blondelle SE, Boulanger MJ, et al. Structure of an autoimmune T cell receptor complexed with class II peptide- MHC: insights into MHC bias and antigen specificity. Immunity (2005) 22:81-92. doi:10.1016/S1074-7613(04)00378-4
24. Wilson DB, Wilson DH, Schroder K, Pinilla C, Blondelle S, Houghten RA, et al. Specificity and degeneracy of T cells. Mol Immunol (2004) 40:1047-55. doi:10.1016/j.molimm.2003.11.022
25. Wooldridge L, Ekeruche-Makinde J, van den Berg HA, Skowera A, Miles JJ, Tan MP, et al. A single autoimmune T cell receptor recognizes more than a million different peptides. J Biol Chem (2012) 287:1168-77. doi:10.1074/jbc. M111.289488
26. Kosmrlj A, Read EL, Qi Y, Allen TM, Altfeld M, Deeks SG, et al. Effects of thymic selection of the T-cell repertoire on HLA class I-associated control of HIV infection. Nature (2010) 465:350-4. doi:10.1038/nature08997
27. Gillespie GM, Kaul R, Dong T, Yang HB, Rostron T, Bwayo JJ, et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS (2002) 16:961-72. doi:10.1097/00002030-200205030-00002
28. Turnbull EL, Lopes AR, Jones NA, Cornforth D, Newton P, Aldam D, et al. HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently. J Immunol (2006) 176:6130-46.
29. Chen H, Ndhlovu ZM, Liu D, Porter LC, Fang JW, Darko S, et al. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection. Nat Immunol (2012) 13:691-700. doi:10.1038/ni.2342
30. Ekeruche-Makinde J, Miles JJ, van den Berg HA, Skowera A, Cole DK, Dolton G, et al. Peptide length determines the outcome of TCR/peptide-MHCI engagement. Blood (2013) 121:1112-23. doi:10.1182/blood-2012-06-437202
31. Ernst B, Lee DS, Chang JM, Sprent J, Surh CD. The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 11:173-81. doi:10.1016/S1074-7613(00)80092-8
32. Starr TK, Daniels MA, Lucido MM, Jameson SC, Hogquist KA. Thymocyte sensitivity and supramolecular activation cluster formation are developmentally regulated: a partial role for sialylation. J Immunol (2003) 171:4512-20.
33. Kirberg J, Berns A, von Boehmer H. Peripheral T cell survival requires continual ligation of the T cell receptor to major histocompatibility complex-encoded molecules. J Exp Med (1997) 186:1269-75. doi:10.1084/jem.186.8.1269
34. Seddon B, Zamoyska R. TCR signals mediated by Src family kinases are essential for the survival of naive T cells. J Immunol (2002) 169:2997-3005.
35. Skipper JC, Gulden PH, Hendrickson RC, Harthun N, Caldwell JA, Shabanowitz J, et al. Mass-spectrometric evaluation of HLA-Akipper JC, Gulde0201-associated peptides identifies dominant naturally processed forms of CTL epitopes from MART-1 and gp100. Int J Cancer (1999) 82:669-77. doi:10.1002/(SICI)1097-0215 (19990827)82:5<669::AID-IJC9>3.0.CO;2-#
36. Ekeruche-Makinde J, Clement M, Cole DK, Edwards ES, Ladell K, Miles JJ, et al. T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J Biol Chem (2012) 287:37269-81. doi:10.1074/jbc. M112.386409
37. Rosenberg SA, Dudley ME. Adoptive cell therapy for the treatment of patients with metastatic melanoma. Curr Opin Immunol (2009) 21:233-40. doi:10.1016/j.coi.2009.03.002
38. Melenhorst JJ, Eniafe R, Follmann D, Molldrem J, Kirby M, El Ouriaghli F, et al. T-cell large granular lymphocyte leukemia is characterized by massive TCRBVrestricted clonal CD8 expansion and a generalized overexpression of the effector cell marker CD57. Hematol J (2003) 4:18-25. doi:10.1038/sj.thj.6200212
39. Mustjoki S, Ekblom M, Arstila TP, Dybedal I, Epling-Burnette PK, Guilhot F, et al. Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy. Leukemia (2009) 23:1398-405. doi:10.1038/leu.2009.46
40. Babbe H, Roers A, Waisman A, Lassmann H, Goebels N, Hohlfeld R, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med (2000) 192:393-404. doi:10.1084/jem.192.3.393
41. Skulina C, Schmidt S, Dornmair K, Babbe H, Roers A, Rajewsky K, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A (2004) 101:2428-33. doi:10.1073/pnas.0308689100
42. Gonzalez-Quintial R, Baccala R, Pope RM, Theofilopoulos AN. Identification of clonally expanded T cells in rheumatoid arthritis using a sequence enrichment nuclease assay. J Clin Invest (1996) 97:1335-43. doi:10.1172/JCI118550
43. Risitano AM, Kook H, Zeng W, Chen G, Young NS, MacIejewski JP. Oligoclonal and polyclonal CD4 and CD8 lymphocytes in aplastic anemia and paroxysmal nocturnal hemoglobinuria measured by V beta CDR3 spectratyping and flow cytometry. Blood (2002) 100:178-83. doi:10.1182/blood-2002-01-0236
44. Felix NJ, Allen PM. Specificity of T-cell alloreactivity. Nat Rev Immunol (2007) 7:942-53. doi:10.1038/nri2200
45. Issa F, Schiopu A, Wood KJ. Role of T cells in graft rejection and transplantation tolerance. Expert Rev Clin Immunol (2010) 6:155-69. doi:10.1586/eci.09.64
46. MacDonald WA, Chen Z, Gras S, Archbold JK, Tynan FE, Clements CS, et al. T cell allorecognition via molecular mimicry. Immunity (2009) 31:897-908. doi:10.1016/j.immuni.2009.09.025
47. Amir AL, van der Steen DM, Hagedoorn RS, Kester MG, van Bergen CA, Drijfhout JW, et al. Allo-HLA reactive T cells inducing graft versus host disease are single peptide specific. Blood (2011) 118:6733-42. doi:10.1182/blood-2011-05-354787
48. D'Orsogna LJ, Nguyen TH, Claas FH, Witt C, Mifsud NA. Endogenous-peptide-dependent alloreactivity: new scientific insights and clinical implications. Tissue Antigens (2013) 81:399-407. doi:10.1111/tan.12115
49. Obst R, Netuschil N, Klopfer K, Stevanovic S, Rammensee HG. The role of peptides in T cell alloreactivity is determined by self-major histocompatibility complex molecules. J Exp Med (2000) 191:805-12. doi:10.1084/jem.191.5.805
50. Welsh RM, Selin LK. No one is naive: the significance of heterologous T-cell immunity. Nat Rev Immunol (2002) 2:417-26.
51. Selin LK, Cornberg M, Brehm MA, Kim SK, Calcagno C, Ghersi D, et al. CD8 memory T cells: cross-reactivity and heterologous immunity. Semin Immunol (2004) 16:335-47. doi:10.1016/j.smim.2004.08.014
52. Wucherpfennig KW, Sethi D. T cell receptor recognition of self and foreign antigens in the induction of autoimmunity. Semin Immunol (2011) 23:84-91. doi:10.1016/j.smim.2011.01.007
53. Zhao Y, Gran B, Pinilla C, Markovic-Plese S, Hemmer B, Tzou A, et al. Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands. J Immunol (2001) 167:2130-41.
54. Siewert K, Malotka J, Kawakami N, Wekerle H, Hohlfeld R, Dornmair K. Unbiased identification of target antigens of CD8+ T cells with combinatorial libraries coding for short peptides. Nat Med (2012) 18:824-8. doi:10.1038/nm.2720